Fever News and Research

RSS

First Edition: June 20, 2013

Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.

20 Jun 2013

Moscamed introduces new programme to control dengue mosquitoes in Jacobina

Today Moscamed made the first releases of Oxitec GM mosquitoes to mark the launch of a new programme to control the dengue mosquito Aedes aegypti in the town of Jacobina in the State of Bahia.

20 Jun 2013

Vaccine given to newborns 60% effective against rotavirus in Ghana

Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration.

18 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study findings first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate the efficacy of canakinumab at tapering corticosteroid (CS) use in patients with SJIA.

14 Jun 2013

Ischaemic heart disease patients at risk after 1 week of treatment

New study data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate a high prevalence of NSAID prescriptions in patients at risk of ischaemic heart disease.

14 Jun 2013

Scientists use mathematical tools to identify animal species that transmit diseases to humans

Spanish and US scientists have successfully identified animal species that can transmit more diseases to humans by using mathematical tools similar to those applied to the study of social networks like Facebook or Twitter.

12 Jun 2013

Hebrew University student develops drug formulations to treat illnesses through skin applications

New, more efficient drug formulations designed to treat illnesses through skin applications -- thus avoiding serious side effects associated with oral drug-taking -- have been developed by a student at the Hebrew University of Jerusalem.

12 Jun 2013

Nimodipine reduces febrile seizures

Fever-induced childhood seizures, known as febrile seizures, can be terrifying for parents to witness. The full-body convulsions, which mostly affect children six months to five years old, can last from mere seconds up to more than 40 minutes. Currently, children are not treated with daily anticonvulsant medication to prevent these seizures even when they recur repeatedly because toxic side effects of existing treatments outweigh potential benefits.

12 Jun 2013

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

10 Jun 2013

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.

7 Jun 2013

Allergic rhinitis treatments: an interview with Dr Dermot Ryan, GP and allergy expert

Allergic rhinitis is most commonly recognized as hay fever in the United Kingdom and it is due to the impact of an allergen, in the case of hay fever a pollen, setting off an inflammatory response in the lungs, causing typical symptoms...

5 Jun 2013

Weather may influence transmission of West Nile, chikungunya, and other viral disease

Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.

4 Jun 2013

New drug shows promising results with manageable side effects for treating melanoma

Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

3 Jun 2013

Researchers target possible new weapon in fight against malaria

Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.

1 Jun 2013

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.

31 May 2013

Taking precautions to protect health during summer

Summer is a time for enjoying warm weather, but spending time outside also increases the risk of contracting serious conditions like Lyme disease, poison ivy rashes, West Nile virus and allergic reactions to bee stings.

31 May 2013

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Mosquito repellent and human odour: an interview with Dr James Logan, London School of Hygiene & Tropical Medicine

Mosquitoes can carry parasites and other organisms that cause deadly diseases such as malaria and dengue fever. So, protecting yourself against their bites is very important.

28 May 2013

Common sugar molecule promising target for development of broad-spectrum vaccine

Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.

28 May 2013

Fever News and Research

First Edition: June 20, 2013

Moscamed introduces new programme to control dengue mosquitoes in Jacobina

Vaccine given to newborns 60% effective against rotavirus in Ghana

European Commission amends marketing authorisation for Celgene's REVLIMID

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Ischaemic heart disease patients at risk after 1 week of treatment

Scientists use mathematical tools to identify animal species that transmit diseases to humans

Hebrew University student develops drug formulations to treat illnesses through skin applications

Nimodipine reduces febrile seizures

NanoViricides files Orphan Drug application with FDA for DengueCide

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Allergic rhinitis treatments: an interview with Dr Dermot Ryan, GP and allergy expert

Weather may influence transmission of West Nile, chikungunya, and other viral disease

New drug shows promising results with manageable side effects for treating melanoma

Researchers target possible new weapon in fight against malaria

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Taking precautions to protect health during summer

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Mosquito repellent and human odour: an interview with Dr James Logan, London School of Hygiene & Tropical Medicine

Common sugar molecule promising target for development of broad-spectrum vaccine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News